Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis

NCT03186755 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Conjunctivitis, Allergic
Conjunctivitis, Vernal

Interventions

DRUG: Hyaluronic acid 0.05% & Ectoine 2.0%
DRUG: Olopatadine hydrochloride ophthalmic solution 0.1%

Sponsor

Michael Marchand, MD

Collaborators

[object Object]